Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Avila

Showing results (571-580 of 626) with videos related to

Pageof 63
Sort By:
British Journal of Cancer|February 18, 2022
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samplesEleonora Loi, Cesare Zavattari, Alessandro Tommasi, et al.
American Journal of Respiratory and Critical Care Medicine|October 8, 2005
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollmentJay H Ryu, Joel Moss, Gerald J Beck, et al.
Journal of Hepatology|April 22, 2021
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targetedAdrián Vallejo, Oihane Erice, Rodrigo Entrialgo-Cadierno, et al.
Clinical Nutrition ESPEN|April 3, 2026
Dietary intervention modifies low-density lipoproteins particle size according to genetic variability: A clinical studyL E González-Salazar, R Guizar-Heredia, A Flores-López, et al.
Gut|January 26, 2017
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regenerationGloria Alvarez-Sola, Iker Uriarte, M Ujue Latasa, et al.
Frontiers in Cell and Developmental Biology|June 22, 2026
Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinomaAmaya Lopez-Pascual, Jasmin Elurbide, Emiliana Valbuena-Goiricelaya, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 20, 2024
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental studyIker Uriarte, Eva Santamaria, Amaya López-Pascual, et al.
Clinical Science (London, England : 1979)|September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell ReprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Pageof 63

Showing results (571-580 of 626) with videos related to

Sort By:
Pageof 63
British Journal of Cancer|February 18, 2022
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samplesEleonora Loi, Cesare Zavattari, Alessandro Tommasi, et al.
American Journal of Respiratory and Critical Care Medicine|October 8, 2005
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollmentJay H Ryu, Joel Moss, Gerald J Beck, et al.
Journal of Hepatology|April 22, 2021
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targetedAdrián Vallejo, Oihane Erice, Rodrigo Entrialgo-Cadierno, et al.
Clinical Nutrition ESPEN|April 3, 2026
Dietary intervention modifies low-density lipoproteins particle size according to genetic variability: A clinical studyL E González-Salazar, R Guizar-Heredia, A Flores-López, et al.
Gut|January 26, 2017
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regenerationGloria Alvarez-Sola, Iker Uriarte, M Ujue Latasa, et al.
Frontiers in Cell and Developmental Biology|June 22, 2026
Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinomaAmaya Lopez-Pascual, Jasmin Elurbide, Emiliana Valbuena-Goiricelaya, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 20, 2024
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental studyIker Uriarte, Eva Santamaria, Amaya López-Pascual, et al.
Clinical Science (London, England : 1979)|September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell ReprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Pageof 63